Correction to: The Edinburgh Consensus: preparing for the advent of disease-modifying therapies for Alzheimer's disease

Craig W Ritchie^{1

2}, Tom C Russ^{3

4

5

6}, Sube Banerjee⁷, Bob Barber⁸, Andrew Boaden⁹, Nick C Fox¹⁰, Clive Holmes¹¹, Jeremy D Isaacs¹², Ira Leroi¹³, Simon Lovestone¹⁴, Matt Norton¹⁵, John O'Brien¹⁶, Jim Pearson¹⁷, Richard Perry¹⁸, James Pickett⁹, Adam D Waldman¹⁹, Wai Lup Wong²⁰, Martin N Rossor¹⁰, Alistair Burns¹³

Affiliations

¹ Centre for Dementia Prevention, University of Edinburgh, 9a Edinburgh Bio Quarter, 9 Little France Road, Edinburgh, EH16 4UX, UK. craig.ritchie@ed.ac.uk.
² Division of Psychiatry, Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK. craig.ritchie@ed.ac.uk.
³ Centre for Dementia Prevention, University of Edinburgh, 9a Edinburgh Bio Quarter, 9 Little France Road, Edinburgh, EH16 4UX, UK.
⁴ Division of Psychiatry, Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK.
⁵ Alzheimer Scotland Dementia Research Centre, University of Edinburgh, Edinburgh, UK.
⁶ Centre for Cognitive Ageing and Cognitive Epidemiology, University of Edinburgh, Edinburgh, UK.
⁷ Centre for Dementia Studies, Brighton and Sussex Medical School, Brighton, UK.
⁸ Old Age Faculty, Royal College of Psychiatrists, London, UK.
⁹ Alzheimer's Society, London, UK.
¹⁰ Dementia Research Centre, Department of Neurodegenerative Disease, UCL, London, UK.
¹¹ Faculty of Medicine, University of Southampton, Southampton, UK.
¹² St George's University Hospitals NHS Foundation Trust, London, UK.
¹³ Division of Neuroscience & Experimental Psychology, University of Manchester, Manchester, UK.
¹⁴ Department of Psychiatry, University of Oxford, Oxford, UK.
¹⁵ Alzheimer's Research UK, Cambridge, UK.
¹⁶ Department of Psychiatry, University of Cambridge, Cambridge, UK.
¹⁷ Alzheimer Scotland, Edinburgh, UK.
¹⁸ Imperial College Healthcare NHS Trust, London, UK.
¹⁹ Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK.
²⁰ East and North Hertfordshire NHS Trust, Stevenage, UK.

PMID: 30060761
PMCID: PMC6065145
DOI: 10.1186/s13195-018-0372-0

Published Erratum

Correction to: The Edinburgh Consensus: preparing for the advent of disease-modifying therapies for Alzheimer's disease

Craig W Ritchie et al. Alzheimers Res Ther. 2018.

. 2018 Jul 30;10(1):73.

doi: 10.1186/s13195-018-0372-0.

Authors

Affiliations

¹ Centre for Dementia Prevention, University of Edinburgh, 9a Edinburgh Bio Quarter, 9 Little France Road, Edinburgh, EH16 4UX, UK. craig.ritchie@ed.ac.uk.
² Division of Psychiatry, Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK. craig.ritchie@ed.ac.uk.
³ Centre for Dementia Prevention, University of Edinburgh, 9a Edinburgh Bio Quarter, 9 Little France Road, Edinburgh, EH16 4UX, UK.
⁴ Division of Psychiatry, Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK.
⁵ Alzheimer Scotland Dementia Research Centre, University of Edinburgh, Edinburgh, UK.
⁶ Centre for Cognitive Ageing and Cognitive Epidemiology, University of Edinburgh, Edinburgh, UK.
⁷ Centre for Dementia Studies, Brighton and Sussex Medical School, Brighton, UK.
⁸ Old Age Faculty, Royal College of Psychiatrists, London, UK.
⁹ Alzheimer's Society, London, UK.
¹⁰ Dementia Research Centre, Department of Neurodegenerative Disease, UCL, London, UK.
¹¹ Faculty of Medicine, University of Southampton, Southampton, UK.
¹² St George's University Hospitals NHS Foundation Trust, London, UK.
¹³ Division of Neuroscience & Experimental Psychology, University of Manchester, Manchester, UK.
¹⁴ Department of Psychiatry, University of Oxford, Oxford, UK.
¹⁵ Alzheimer's Research UK, Cambridge, UK.
¹⁶ Department of Psychiatry, University of Cambridge, Cambridge, UK.
¹⁷ Alzheimer Scotland, Edinburgh, UK.
¹⁸ Imperial College Healthcare NHS Trust, London, UK.
¹⁹ Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK.
²⁰ East and North Hertfordshire NHS Trust, Stevenage, UK.

PMID: 30060761
PMCID: PMC6065145
DOI: 10.1186/s13195-018-0372-0

Abstract

Since the publication of this article [1], it has come to the attention of the authors that information for one of the authors was not included in the competing interests section. Craig Richie has declared potential competing interests with the following companies; Janssen, Eisai, Pfizer, Eli Lilly, Roche Diagnostics, Boeringher Ingleheim, Novartis, AC Immune, Ixico, Aridhia, Amgen, Berry Consultants, Lundbeck, Sanofi, Quintiles (IQVIA) and Takeda. The full competing interests section for this article can be found below.

PubMed Disclaimer

Erratum for

The Edinburgh Consensus: preparing for the advent of disease-modifying therapies for Alzheimer's disease.
Ritchie CW, Russ TC, Banerjee S, Barber B, Boaden A, Fox NC, Holmes C, Isaacs JD, Leroi I, Lovestone S, Norton M, O'Brien J, Pearson J, Perry R, Pickett J, Waldman AD, Wong WL, Rossor MN, Burns A. Ritchie CW, et al. Alzheimers Res Ther. 2017 Oct 26;9(1):85. doi: 10.1186/s13195-017-0312-4. Alzheimers Res Ther. 2017. PMID: 29070066 Free PMC article.

References

1. Ritchie C, et al. The Edinburgh Consensus: preparing for the advent of disease-modifying therapies for Alzheimer’s disease. Alzheimer's Research & Therapy. 2017;9:85. 10.1186/s13195-017-0312-4. - PMC - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Correction to: The Edinburgh Consensus: preparing for the advent of disease-modifying therapies for Alzheimer's disease

Affiliations

Correction to: The Edinburgh Consensus: preparing for the advent of disease-modifying therapies for Alzheimer's disease

Authors

Affiliations

Abstract

Erratum for

References

Publication types

Grants and funding

LinkOut - more resources

Full Text Sources

Other Literature Sources